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Abstract 
Purpose: Lacunar infarcts are thought to result from occlusion of small penetrating arteries due to 
microatheroma and lipohyalinosis, pathognomonic for cerebral small vessel disease (CSVD). Concurrent 
embolic ischemic lesions indicate a different stroke mechanism. The purpose of this study was to examine 
clinical characteristics and outcome of patients with lacunar infarcts and concurrent embolic infarcts on 
diffusion weighted imaging (DWI).  
Methods: All patients screened for the WAKE-UP trial (Efficacy and Safety of MRI-based Thrombolysis in 
Wake-Up Stroke; ClinicalTrials.gov number, NCT01525290) were reviewed for acute lacunar infarcts and 
concurrent embolic lesions on baseline DWI. Clinical characteristics and outcome were compared between 
lacunar infarct patients with and without concurrent embolic lesions.  
Results: Of 244 patients with an acute lacunar infarct, 20 (8.2%) had concurrent acute embolic infarcts. 
Compared to patients with a lacunar infarct only, patients with concurrent embolic infarcts were older (mean 
age 69 vs. 63 years; p = 0.031), more severely affected (median National Institutes of Health Stroke Scale 
[NIHSS] score 5 vs. 4; p = 0.046), and - among those patients randomized – had worse functional outcome at 90 
days (median modified Rankin Scale [mRS] 3 vs. 1; p = 0.011).  
Conclusions: About 8% of lacunar infarct patients show concurrent embolic lesions suggesting stroke etiology 
other than CSVD. These patients are more severely affected and have a worse functional outcome illustrating 
the need for a thorough diagnostic workup of possible embolic sources even in patients with imaging-defined 
diagnosis of lacunar infarcts. 
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Introduction 
Lacunar infarcts are defined as small subcortical ischemic lesions in the territory of thin penetrating arteries and 
account for about 20% to 30% of all ischemic strokes [1, 2]. With regard to pathophysiology, lacunar infarcts 
are considered to result from occlusion of small penetrating arteries due to microatheroma and lipohyalinosis, 
both pathognomonic findings in cerebral small vessel disease (CSVD) [3]. Based on this assumption, the 
diagnosis of a lacunar stroke from an occlusion of a single penetrating artery may result in limited diagnostic 
efforts as to potential embolic sources of stroke. 
In a small proportion of patients with acute lacunar infarcts, additional cortical infarcts can be observed, 
suggesting an embolic etiology [4-6]. This challenges the generality of the assumption that local small vessel 
pathology is the leading cause of lacunar infarction [5]. 
We investigated individual data of patients screened for the WAKE-UP trial (efficacy and safety of MRI-based 
thrombolysis in wake-up stroke) [7]. We sought to examine the frequency of concurrent embolic lesions, and to 
explore whether the two patient groups differed in clinical characteristics and functional outcome. 
 
 
Methods 
Study design 
WAKE-UP was a multicenter-randomized, double blind, placebo-controlled trial to study MRI-based 
intravenous thrombolysis in unknown onset stroke. The detailed trial protocol and the results of the original 
paper are described elsewhere [7]. For this secondary analysis, we investigated individual data of all screened 
patients for acute lacunar infarcts and simultaneous acute embolic ischemic lesions on screening MRI, 
performed within 4.5 hours of symptom recognition [7]. Patients or their legal representatives provided written 
informed consent according to national and local regulations. There was an exception from explicit informed 
consent in emergency circumstances in some countries. The trial was approved for each study site by the 
competent authorities and the corresponding ethics committee. Acute ischemic lesions were identified as a 
hyperintense signal on DWI and a reduced apparent diffusion coefficient (ADC) in the corresponding brain 
region. According to the neuroimaging criteria of the STRIVE position paper, we defined lacunar infarcts as 
acute subcortical lesions in the territory of penetrating arteries, located in the deep grey or white matter of the 
cerebral hemispheres or brainstem and with a maximum diameter of 20 mm on axial plane on DWI [2]. 
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Concurrent embolic ischemic lesions were diagnosed in cases of territorial or small punctuate cortical lesions 
(for examples see Fig. 1). Two neurologists, blinded to clinical information, assessed the imaging data. 
Vascular risk factors were recorded, and neurological deficits on admission were assessed using the NIHSS. For 
differentiation of clinical signs indicating cortical involvement individual NIHSS items were evaluated 
additionally. We determined neglect and aphasia as clinical signs of cortical involvement by any score >0 on 
NIHSS items 9 (“Language/aphasia”) and 11 (“Extinction/inattention”). Outcome parameters were assessed in 
randomized patients only. The mandatory imaging criterion for randomization to treatment with alteplase or 
placebo was a mismatch between an acute ischemic lesion visible on DWI and no corresponding parenchymal 
hyperintensity on fluid-attenuated inversion recovery (FLAIR), indicating a stroke onset most likely within the 
previous 4.5 hours. As initially defined in the WAKE-UP trial primary outcome measure was functional 
outcome assessed by the modified Rankin scale (mRS) at 90 days after stroke. Further outcomes included 
favorable outcome (mRS 0-1), mortality, death or dependence (mRS score 4-6), and symptomatic intracranial 
hemorrhage (SICH) according to the SITS-MOST criteria [8]. 
 
Statistical analysis 
Clinical characteristics and outcome were compared between patients with a lacunar infarct only and those with 
concurrent ischemic lesions other than lacunar infarcts using the non-parametric Mann-Withney test for 
continuous outcomes, the Fisher exact test for categorical outcomes, and the Mantel-Haenszel Chi-square test 
for ordinal outcomes. Statistical analyses of outcome parameters in lacunar infarcts were performed for 
randomized patients with available information on clinical endpoints. As all analyses were considered 
exploratory, all tests were carried out with a two-sided alpha level of 5% without correction for multiple 
comparisons.  
 
 
Results 
Of 1362 patients enrolled and screened by MRI in WAKE-UP, 1085 patients had an acute ischemic lesion on 
DWI. Of these, 244 (22.5%) patients presented with an imaging-defined lacunar infarct (108 were randomized 
after screening with MRI, 136 were screen failures as they did not meet all inclusion and exclusion criteria). In 
20 (8.2%) lacunar infarct patients concurrent ischemic lesions other than lacunar infarcts were observed. Six 
patients had single concurrent embolic lesions, while 14 patients presented with multiple simultaneous embolic 
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lesions. Occlusion of an intracranial cerebral artery was present on time-of-flight MR-angiography in three 
patients with a lacunar infarct and concurrent multiple embolic infarcts, and two of them had simultaneous 
territorial infarcts.  
Patients with concurrent embolic infarcts were significantly older (mean age 69 vs. 63 years; p = 0.031), more 
severely affected (median NIHSS score 5 vs. 4; p = 0.046), and showed a trend of a higher prevalence of 
cortical symptoms such as aphasia and/or neglect (35.0% vs. 16.1%; p = 0.059) than those with a lacunar infarct 
only (see table). Other baseline parameters and risk factors were comparable between the two groups.  
Information on functional outcome was available in 105 (43.0%) of 244 patients with lacunar infarcts (100 
patients with a single lacunar infarct and five patients with concurrent embolic infarcts). Patients with 
concurrent embolic infarcts had a worse functional outcome at 90 days after stroke (median mRS 3 vs. 1; p = 
0.011). Favorable outcome (mRS score 0-1) was observed in 55 (55%) patients with a single lacunar infarct but 
in none of the patients with concurrent embolic lesions. 
SICH was observed in a single patient with a lacunar infarct only, leading to a fatal outcome. Dependence (mRS 
4-5) occurred in six patients (6%) with a lacunar infarct only, and in one lacunar infarct patient (20%) with 
concurrent embolic lesion. 
 
 
Discussion 
In the present subgroup analysis of patients enrolled in the WAKE-UP trial, 8% of lacunar infarct patients 
showed concurrent acute embolic infarcts on DWI. Lacunar stroke patients with concurrent embolic lesions 
were older, more severely affected with a higher prevalence of cortical symptoms, and, among the subgroup of 
randomized and followed up to day 90, had a worse functional outcome than patients with a lacunar infarct only. 
The distribution of lacunar and nonlacunar infarcts was similar both in randomized (21.5%) as well as not-
randomized patients with ischemic lesions on DWI (23.4%), and was also comparable to distributions reported 
previously [1, 9]. 
Lacunar infarcts are considered pathognomonic for CSVD and, according to the lacunar hypothesis, are mainly 
caused by occlusion of small penetrating arteries due to microatheroma and lipohyalinosis, secondary to 
hypertension and diabetes [3]. Though embolism is not assumed as being part of the pathophysiology of lacunar 
infarcts, in fact, C. Miller Fisher was the first to suggest an embolic mechanism as a possible stroke cause in 
lacunar infarcts. In his autopsy series of ten patients with capsular infarcts, in two patients the perforating 
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arteries supplying the infarcted area did not show any pathologies [10]. As atheroma and lipohyalinosis would 
be considered constantly present pathological changes of the vascular structure, Fisher therefore speculated that 
in those two cases the stroke might have been caused by embolic material that presumably has disappeared over 
time. Further autopsy studies followed and Fisher’s findings were confirmed in an autopsy case of a woman 
with multiple lacunar and cortical infarcts due to cholesterol emboli from atheromatous changes in the aortic 
arch [11].  
The possibility of embolism as a relevant cause of lacunar infarcts is also supported by animal experiments. 
Contrary to the assumption that embolic material is unlikely to enter penetrating arteries due to their sharp 
angles with the parent vessel, models of various generated embolic sources in rodents and primates 
demonstrated that embolic material can enter small perforating arteries and, thereby, cause lacunar infarcts [12, 
13]. Furthermore, animal studies supporting the hypothesis that lacunar infarcts result from microatheroma or 
lipohyalinosis due to hypertension and diabetes are lacking [14]. Finally, with the introduction of MRI with 
DWI as a highly sensitive diagnostic tool to detect even small acute ischemic brain lesions, simultaneous 
presence of acute lacunar and cortical infarcts was observed, suggesting an underlying embolic mechanism as 
common etiology rather than CSVD [6], e.g., cardiac or aortic embolism, or pathologies of the internal carotid 
or the basilar artery [4, 5, 15-17].  
Importantly, the lacunar hypothesis of CSVD as major underlying etiology has resulted in often limited 
diagnostic workup with regard to embolic sources in patients with an imaging diagnosis of lacunar infarction. 
However, patients with imaging-defined lacunar infarcts show a higher rate of other risk factors that might 
indicate a mechanism different than CSVD and it is not possible to identify the stroke cause from the size, shape 
or location of an ischemic lesion considered lacunar [18]. Indications for a stroke mechanism other than CSVD 
can be derived from clinical symptoms referring to cortical involvement, cardiac or vascular comorbidities 
suggesting an embolic mechanism of infarct, and advanced brain imaging such as MRI. Therefore, especially in 
the context of concurrent acute embolic infarcts in patients with lacunar stroke, an extensive search for other 
stroke mechanisms such as cardiac embolism or large artery atherosclerosis should be undertaken, as effective 
secondary prevention relies on the identification of the underlying etiology.  
There are limitations to our analysis. As our study is a secondary exploratory analysis and the number of 
patients with available information on clinical outcome is small, any results should be considered hypothesis-
generating. In addition, the WAKE-UP study protocol did not require the evaluation of stroke etiology based on 
a comprehensive diagnostic workup. Information on clinical evaluation required by the trial protocol, was 
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limited to the standard assessment of stroke symptoms based on the NIHSS. Although scores >0 on NIHSS 
items “Language/aphasia” and “Extinction/inattention” likely indicate cortical involvement, we do not have 
available results of a detailed neurological examination and we lack information on the final clinical assessment 
of stroke etiology. Diagnosis of lacunar infarcts was based on imaging findings only, following the STRIVE 
consensus criteria. 
In line with previous autopsy and MRI studies, the finding of a relevant proportion of concurrent acute embolic 
ischemic lesions in patients with lacunar infarcts suggests that embolism needs to be considered as potential 
stroke etiology, even in patients with imaging-defined acute infarcts consistent with a lacunar infarct. The 
choice of the modality for imaging of acute stroke patients depends on numerous factors including availability 
as well as the individual patient’s characteristics. CT is currently the prevailing modality for acute stroke 
imaging. However, MRI as first imaging modality for acute ischemic stroke has shown to be both feasible [19] 
as well as cost-effective [20]. In lacunar stroke, the use of DWI to detect multiple acute infarcts may provide 
helpful information on stroke etiology and may improve the planning of diagnostic tests and effective 
preventive strategies.   
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Figure Legend 
Fig. 1 Exemplary MRI findings in lacunar infarct patients 
Axial diffusion weighted MRI images of a patient with a lacunar infarct in the left posterior corona radiata and a 
single cortical embolic infarct in the territory of the left anterior cerebral artery (upper row, A), a patient with a 
lacunar infarct in the left internal capsule and multiple cortical embolic infarcts in the territory of the left middle 
cerebral artery (middle row, B) and a patient with a lacunar infarct in the left thalamus showing multiple cortical 
embolic infarcts in the territory of the right posterior and the left middle cerebral artery, and a territorial infarct 
of the right middle artery (lower row, C). Lacunar infarcts are marked with black arrows, embolic infarcts with 
thin white arrows and the territorial infarct with a thick white arrow. 
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Table 1 Baseline data of lacunar infarct patients 
 
Variable Lacunar 
Infarcts (n=224) 
Lacunar and 
cortical infarcts 
(n=20) 
p-value 
Age - years       
   Mean (SD) 63 (11) 69 (9) 0.031 
Male sex - number (%) 148 (66) 16 (80) 0.319 
Treatment allocated - no. (%)       
   Alteplase 54 (24.1) 1 (5)   
   Placebo 49 (21.9) 4 (20) 0.09 
   Not randomized 121 (54.0) 15 (75)   
Time between last seen well and symptom recognition - hours       
   Median (interquartile range) 7 (4.8-8.8) 7.5 (5-9) 0.819 
Medical history/risk factors - no. (%)       
   Arterial hypertension 124 (55.4) 9 (45) 0.525 
   Diabetes mellitus 41 (18.3) 4 (20) 0.824 
   Hypercholesterolemia 73 (32.6) 4 (20) 0.315 
   Atrial fibrillation 5 (2.2) 0 1.0 
   History of ischemic stroke 26 (11.6) 4 (20) 0.399 
NIHSS score       
   Median (interquartile range) 4 (3-6) 5 (4.5-8) 0.046 
   Cortical symptoms - number (%)* 36 (16.1) 7 (35.0) 0.059 
DWI lesion volume at baseline - ml       
   Median (interquartile range) 0.73 (0.21-1.19) 1.06 (0.33-1.94) 0.134 
Time from symptom recognition to MRI - hours       
   Median (interquartile range) 3.0 (2.3-3.8) 3.1 (2.2-3.7) 0.748 
 
DWI = diffusion weighted imaging; MRI = magnetic resonance imaging; NIHSS = National Institute of Stroke 
Scale; *Cortical symptoms were assessed by a score >0 on NIHSS items 9 “Language/aphasia” or 11 
“Extinction/inattention”. 
 
